# FDA Warning Letter: Maitland Labs of Central Florida
> 2021-08-17 · Office of Pharmaceutical Quality Operations, Division II · `7a2f8329d2e8e90d`
## Letter
- **Company:** Maitland Labs of Central Florida
- **Posted Date:** 2021-08-17
- **Letter Issue Date:** 2021-08-06
- **Issuing Office:** Office of Pharmaceutical Quality Operations, Division II
## Subject
Compounding Pharmacy/Adulterated Drug Products
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*